Comirnaty Description

Bretovameran is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 (JN.1).
3 mcg: The vaccine is a white to off-white clear to slightly opalescent suspension (pH: 6.9 - 7.9).
This is a multidose vial with a yellow cap and must be diluted before use.
One vial (0.48 mL) contains 3 doses of 0.3 mL after dilution, see Dosage & Administration and Special Precautions for Disposal and Other Handling under Cautions for Usage.
One dose (0.3 mL) contains 3 micrograms of bretovameran, a COVID-19 mRNA Vaccine (nucleoside modified, embedded in lipid nanoparticles).
10 mcg: The vaccine is a clear to slightly opalescent suspension (pH: 6.9 - 7.9).
This is a single dose with a blue cap. Do not dilute prior to use.
One single dose vial contains 1 dose of 0.3 mL, see Dosage & Administration and Special Precautions for Disposal and Other Handling under Cautions for Usage.
One dose (0.3 mL) contains 10 micrograms of bretovameran, a COVID-19 mRNA Vaccine (nucleoside modified, embedded in lipid nanoparticles).
30 mcg: The vaccine is a white to off-white suspension (pH: 6.9 - 7.9).
This is a single dose or a multidose vial, or a single dose pre-filled syringe. The single dose vial and multidose vial have a grey cap. Do not dilute prior to use. (See Table 1.)

Click on icon to see table/diagram/image

Excipients/Inactive Ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315), 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159), 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC), Cholesterol, Trometamol, Trometamol hydrochloride, Sucrose, Water for injections.